Single marker association results in individual Finnish and Swedish patients positive for Ro/SSA-autoantibody as well as in a combined dataset1.

The frequency of the associated allele in controls and cases is shown, as well as its uncorrected P-value, and P-value corrected for multiple testing (in parentheses) as well as odds ratio (OR) with 95% confidence interval (CI).1The Finnish sample set consists of sporadic patients with DLE (n = 36), SCLE (n = 25) and SLE (n = 40) [15]. Ro/SSA information was not available for SLE family probands. The Swedish sample set consists of 21 Ro-positive patients without signs of systemic inflammation, 6 patients with UCTD, 2 DLE, 8 SCLE, 31 SLE, and 66 SS patients.

本研究展示了关联等位基因在对照组与病例组中的分布频率，及其未校正P值、经多重检验校正后的P值（校正后P值标注于括号内），同时给出比值比（odds ratio, OR）与95%置信区间（confidence interval, CI）。1. 芬兰队列纳入的均为散发性患者，其中盘状红斑狼疮（Discoid Lupus Erythematosus, DLE）患者36例、亚急性皮肤型红斑狼疮（Subacute Cutaneous Lupus Erythematosus, SCLE）患者25例、系统性红斑狼疮（Systemic Lupus Erythematosus, SLE）患者40例[15]。系统性红斑狼疮（SLE）家系先证者的Ro/SSA相关信息未被纳入统计。瑞典队列则纳入21例无全身炎症征象的Ro抗体阳性患者、6例未分化结缔组织病（Undifferentiated Connective Tissue Disease, UCTD）患者、2例盘状红斑狼疮（DLE）患者、8例亚急性皮肤型红斑狼疮（SCLE）患者、31例系统性红斑狼疮（SLE）患者，以及66例干燥综合征（Sjögren's Syndrome, SS）患者。